BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2021 8:38:05 AM | Browse: 509 | Download: 1115
 |
Received |
|
2020-12-31 05:37 |
|
Peer-Review Started |
|
2020-12-31 05:38 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-23 03:33 |
|
Revised |
|
2021-03-04 10:26 |
|
Second Decision |
|
2021-04-09 08:25 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-04-09 18:14 |
|
Articles in Press |
|
2021-04-09 18:14 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-04-20 09:11 |
|
Typeset the Manuscript |
|
2021-05-19 00:51 |
|
Publish the Manuscript Online |
|
2021-05-20 08:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Shao-Long Chen, Guo-Ping Wang, Dan-Rong Shi, Shu-Hao Yao, Ke-Da Chen and Hang-Ping Yao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Sciences Foundation of China |
81872883 |
| Zhejiang Major Medical Health & Sciences Technology Foundation Projects |
WKJ-ZJ-13 |
|
| Corresponding Author |
Hang-Ping Yao, PhD, Professor, State Key Laboratory for Diagnosis and Treatment of Infectious Disease, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Shangcheng District, Hangzhou 310000, Zhejiang Province, China. yaohangping@zju.edu.cn |
| Key Words |
RON; Signal transduction; Hepatobiliary; Pancreatic neoplasms; Molecular targeted therapy |
| Core Tip |
The role of RON in cancer pathogenesis has received increased research attention. Hepatobiliary and pancreatic (HBP) cancers have poor prognosis, being reported as having higher rates of cancer-related death because of their high rates of recurrence, metastasis, and invasiveness, and their lack of sensitivity to chemotherapy. In this review, we discuss how RON functions in HBP cancers pathogenesis, as well as its potential role as a therapeutic target in HBP cancers. |
| Publish Date |
2021-05-20 08:38 |
| Citation |
Chen SL, Wang GP, Shi DR, Yao SH, Chen KD, Yao HP. RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets. World J Gastroenterol 2021; 27(20): 2507-2520 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i20/2507.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i20.2507 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
